AMP-activated protein kinase (AMPK) is a master cellular energy sensor that has received much attention as a promising therapeutic target for obesity-associated metabolic disorders, including NAFLD/NASH8–11. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.